neurocare

Private

MunichHealthcare & Life Scienceshttps://www.neurocaregroup.com/

Last Round

Early Funding

Feb 5, 2025

Total Funding Raised

$37.11M

Momentum

Quiet

No recent growth signals

Company Overview

neurocare is a healthcare technology company that provides a digital therapy platform to empower clinicians with personalized treatment for mental health conditions.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical Devices, Vertical SaaS

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

integrated mental healthcare platformdigital therapy platform for cliniciansTranscranial Magnetic Stimulation (TMS) systemsintegrated neuromodulation and psychotherapymental health clinic networkneuromodulation device manufacturerEEG and QEEG systemstreatment for treatment-resistant depressionneurofeedback and tDCS/tACS/tRNS systemsclinician training for neuromodulationmental healthcare for depression, ADHD, and OCD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

neurocare Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

neurocare Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Early Funding	Feb 5, 2025
Series A	Apr 24, 2024
Strategic	Jul 2, 2020
Strategic	Jul 1, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Kevin Reeder

Chief Financial Officer

Executive Team

neurocare Investors

Notable investors and investment history

Investor	Rounds
re.Mind Capital	Strategic
TVM Capital Healthcare	Early Funding, Series A
bm\|t beteiligungsmanagement thüringen	Strategic, Series A
Aescuvest	Series A
Impact Expansion	Early Funding

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 5, 2025
$20.1M raised from TVM Capital Healthcare and Impact Expansion.
Apr 24, 2024
$17M round led by TVM Capital Healthcare.

View all signals

neurocare Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

neurocare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about neurocare's valuation, stock price, and market status.

Firmographic Details

HeadquartersMunich

Employee Range158

Year Founded2015

Last FundingFeb 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.